Lista de obras -

11q21 Rearrangement is a Frequent and Highly Specific Genetic Alteration in Mucoepidermoid Carcinoma ⬇️

artículo científico publicado el 1 de septiembre de 2012

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice

artículo científico publicado en 2020

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up ⬇️

artículo científico publicado el 14 de febrero de 2013

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC

artículo científico publicado en 2020

Current status of therapeutic approaches with targeted therapies in malignant thyroid cancer. Highlights from the 2011 ASCO Congress ⬇️

artículo científico publicado el 1 de mayo de 2012

Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year’s literature ⬇️

artículo científico publicado el 22 de marzo de 2012

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy

artículo científico publicado en 2020

HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1 ⬇️

artículo científico publicado el 7 de agosto de 2013

Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy

artículo científico publicado en 2020

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer

artículo científico publicado en 2021

Molecular targeting agents in the context of primary chemoradiation strategies ⬇️

artículo científico publicado el 20 de enero de 2012

New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress ⬇️

artículo científico publicado el 1 de mayo de 2012

New treatment strategies for HPV-positive head and neck cancer ⬇️

artículo científico publicado el 10 de agosto de 2013

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status

scientific article published on 26 August 2019

Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma

artículo científico publicado en 2020

Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)

artículo científico publicado en 2020

The development of TORS in Europe ⬇️

artículo científico publicado el 1 de abril de 2013

The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting ⬇️

artículo científico publicado el 1 de noviembre de 2012

Lista de obras de

11q21 Rearrangement is a Frequent and Highly Specific Genetic Alteration in Mucoepidermoid Carcinoma ⬇️

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up ⬇️

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC

Current status of therapeutic approaches with targeted therapies in malignant thyroid cancer. Highlights from the 2011 ASCO Congress ⬇️

Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year’s literature ⬇️

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy

HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1 ⬇️

Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy

Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer

Molecular targeting agents in the context of primary chemoradiation strategies ⬇️

New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress ⬇️

New treatment strategies for HPV-positive head and neck cancer ⬇️

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status

Peripheral Cytokine Levels Differ by HPV Status and Change Treatment-Dependently in Patients with Head and Neck Squamous Cell Carcinoma

Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC)

The development of TORS in Europe ⬇️

The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting ⬇️